Imaging, QoL and Patient-Reported Outcome and Supportive Care

(PA-113) Time Constraints and Treatment Decisions: How Time Allowed for Decision Making Affects Patient Experience in Relapsed Refractory Multiple Myeloma

(PA-114) Role of the Combination of 3 T Whole-body MRI and 18F-FDG PET/CT in the Management of Multiple Myeloma and Smoldering Myeloma: The New Era of Imaging

(PA-115) An Orthopaedic-guided Exercise Intervention for Newly Diagnosed Multiple Myeloma Patients Is Feasible, Safe and Improves Patient-reported Outcomes (GMMG-HD8-INDEX Trial)

(PA-116) Progression Patterns by Positron Emission Tomography (PET) for Relapsed / Refractory Multiple Myeloma (RRMM) After CAR T Cell Therapy: Potential Role for Radiotherapy (RT)?

(PA-117) Optimisation of Patient-reported Outcome Measurement (PROMs) for Patients with Haematological Cancer Receiving CAR-T and Bispecific Antibodies: Multi-stakeholder Perspectives

(PA-118) Assessing the Correlation Between Canadian Multiple Myeloma Patients’ and Caregivers’ Perceived Quality of Life and Assessments of Validated Quality of Life Instruments

(PA-119) When ICAN(S) Becomes ICAN’T: Clinician and Staff Perspectives on In-Hospital Neurotoxicity Grading

(PA-120) Prognostic of Baseline 18F-FDG PET/CT in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma

(PA-121) Patient-reported Quality of Life with Linvoseltamab in Triple-class Exposed Patients with Relapsed/refractory Multiple Myeloma: 2-year Results from the LINKER-MM1 Phase 1/2 Clinical Trial

(PA-122) Inadequate Racial Reporting Among References Forming the Basis of NCCN Guidelines for Multiple Myeloma and Systemic Light Chain Amyloidosis

(PA-123) Optimizing Skeletal Health: A Retrospective Analysis of Bone-modifying Agent Prescription Patterns and Incidence of Skeletal-related Events in Multiple Myeloma

(PA-124) Evaluating the Most Influential Factors in Decision-Making in Women and Men with Relapsed Multiple Myeloma

(PA-125) Physical Activity Patterns, Barriers, and Motivators in Multiple Myeloma and Precursor Disease Patients: A Cross-Sectional Survey

(PA-126) Post-Traumatic Growth, Flourishing, and Spiritual Practice Among Adults with Blood Cancer: A Patient-Reported Wellbeing Cross-Sectional Study

(PA-127) Survey-based Research into Patient-physician Communication and Treatment Decision-making Preferences in Newly Diagnosed Multiple Myeloma

(PA-128) Measles Antibody IgG Levels in Treatment Exposed Patients with Multiple Myeloma

(PA-129) Co-designing an Implementation Strategy for a Nurse and Pharmacist-led Intervention Addressing the Long-term Needs of Patients Living with Multiple Myeloma (MM)

(PA-131) Gender Disparities in Sexual Health Communication Among Patients with Multiple Myeloma: a HealthTree Patient Based Survey Study

(PA-132) Current Survival and Causes of Mortality of Myeloma Patients in Real Word Setting

(PA-133) Update of the EORTC Quality of Life Multiple Myeloma module (EORTC QLQ-MY20). Results from the Phase I-II EORTC prospective study

(PA-134) Factors Influencing the Outcome of Salvage Second Autologous Stem Cell Transplant in Relapsed Multiple Myeloma

(PA-135) Evaluating the Efficacy and Tolerability of PJP Prophylaxis with TMP-SMX in Autologous Stem Cell Transplants for Lymphoma or Myeloma: A Retrospective Cohort Study

(PA-136) An Effective Lenalidomide Desensitization for Delayed Hypersensitivity-induced Rash in Patients with Multiple Myeloma

(PA-137) Predicting Early Mortality Risk in Newly Diagnosed Multiple Myeloma Patients

(PA-138) Health-related Quality of Life in a "Real-world" Cohort of Chilean Patients with Multiple Myeloma

(PA-139) Romosozumab for Patients with Multiple Myeloma with Skeletal Events on Zoledronic Acid

(PA-140) Imaging Quality and Detection Ability of Whole-body Low-dose CT for Bone and Extraosseous Lesions in Multiple Myeloma

(PA-141) The Optimising Outcomes in Myeloma Patients with Frailty (OOMPF) Study

(PA-142) Assessment of Extraosseous Multiple Myeloma Using Whole-Body Imaging Techniques: PET/CT, MRI, and MIBI

(PA-143) mQOL, a Text-based Remote Therapeutic Monitoring (RTM) Platform for Symptom (Sx) and Quality of Life (QoL) Tracking in Multiple Myeloma (MM): Interim Results from a Prospective Observational Study

(PA-144) Whole Body Magnetic Resonance Imaging (WBMRI) for Response Evaluation in Patients with Multiple Myeloma

(PA-145) Treatment-Free Hospitalization-Free Time With CAR T-Cell Therapy Versus Standard Regimens and Quality of Life Implications in Patients With Relapsed/Refractory MM: Findings From the KarMMa-3 Trial

(PA-146) Abstract: The Role of Caregivers in Multiple Myeloma Care: A Social Work Perspective at the Ampath Multiple Myeloma Program (AMMP)

(PA-147) Nutritional Status of Adults with Multiple Myeloma and Its Association with Disease Progression and Survival

(PA-148) Infectious Complications in Patients with Multiple Myeloma: A Scoping Review

(PA-149) Daratumumab versus Lenalidomide Maintenance Therapy in Newly Diagnosed Multiple Myeloma – Quality of Life and Efficacy Results from a Randomized Investigator-initiated Trial

(PA-150) Obesity as a Prognostic Factor in Newly Diagnosed Multiple Myeloma in a Mexican Population

(PA-151) Identification of Extracardiac Organ Involvement in Systemic Light Chain Amyloidosis Using 18f-florbetaben Positron Emission Tomography

(PA-152) PRO-Guided Treatment Readiness for Daratumumab in Myeloma: Feasibility and Accuracy

(PA-153) Operationalising Patient Selection for Outpatient Transplant in Multiple Myeloma: Subjective versus Objective Measures

(PA-154) Health-Related Quality of Life in Indian Patients with Multiple Myeloma: A Pan-India Digital Survey-Based Assessment

(PA-155) Diagnostic Potential of Shear Wave Elastography for Liver Involvement in AL Amyloidosis

(PA-156) "Challenges in Diagnosis, Treatment Access, and Quality of Life Among Newly Diagnosed Multiple Myeloma Patients in India: Findings from a Prospective Observational Study"

(PA-157) Incidence and Risk Factors of Thromboembolic Events in Chinese Patients with Multiple Myeloma: A Single-Center Retrospective Cohort Study

(PA-158) The HSCT-BIOME Study: Double-blinded, Randomized, Placebo-controlled Trial Using Orally-administered, Lyophilized Faecal Microbiota Transplantation to Prevent Hsct-associated Complications

(PA-159) Performance of Deauville Score and Total Lesion Glycolysis as Response Markers for Multiple Myeloma with Extramedullary Disease

(PA-160) Dialysis-dependence Is Associated with Poor Prognosis in Multiple Myeloma: A Multicenter Retrospective Cohort Study

(PA-521) Evolution of Age and Causes of Death in Patients with Multiple Myeloma in the Era of Novel Agents

(PA-526) Patterns of Use of Free Light Chain Testing in Patients with Multiple Myeloma in Colombia

(PA-529) Risk of Infections After Bispecific Antibodies Targeting Anti-B-cell Maturation Antigen (BCMA) in Multiple Myeloma- intravenous Immunoglobulin (IVIG) Significantly Lowers the Risk of Infection

(PA-530) Second Primary Tumor in Patients with Multiple Myeloma in Brazil: A Population-Based Study